Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a non-functional pseudogene in the cytochrome P450 superfamily, which includes enzymes that typically function as monooxygenases for a range of endogenous and exogenous substrates[2][4]. As a pseudogene, CYP4F62P is not believed to encode an active protein and thus has no known biological function, no therapeutic relevance, and no direct disease associations[4]. Pseudogenes such as CYP4F62P are usually byproducts of gene duplication or retrotransposition and do not code for functional enzymes, though in rare cases they may play a regulatory nucleic acid role[4]. The presence of "pseudogene" in the name and the ENSG identifier corresponding to a pseudogene both confirm its non-functional status[4]. No information linking this pseudogene to drug interaction, disease association, or biomarker status is available. If you are seeking a functional cytochrome P450 enzyme, like CYP3A4 or CYP2D6, those are widely studied drug targets[2]. This entry is not a practical target for drug discovery or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450, family 4, subfamily F, polypeptide 62 pseudogene (CYP4F62P).